2202: GLP‑1 Gold Rush: MedPal AI’s CEO on Turning a £45k Deal into a £100bn Opportunity

from The Vox Markets Podcast · host Vox Markets Podcast

MedPal AI has just acquired a licensed online pharmacy and raised £550k to support its next big move: entering the fast-growing GLP‑1 weight-loss market. With drugs like Ozempic and Mounjaro in high demand — and online prescribing facing tighter regulation — MedPal is combining AI health coaching with compliant, NHS-linked pharmacy fulfilment. CEO Jason Drummond joins Vox Markets to break down the deal, the strategy, and what’s next.

NOW PLAYING

0:00 8:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Vox Markets Podcast?

This episode is 8 minutes long.

When was this The Vox Markets Podcast episode published?

This episode was published on October 2, 2025.

What is this episode about?

Can I download this The Vox Markets Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!